NADPH cytochrome P-450 reductase activation of quinone anticancer agents to free radicals.
about
Doxorubicin cardiomyopathyChemotherapy-Induced Cardiotoxicity: Overview of the Roles of Oxidative StressEffect of photodynamic therapy in combination with mitomycin C on a mitomycin-resistant bladder cancer cell lineA switching mechanism in doxorubicin bioactivation can be exploited to control doxorubicin toxicityKinetic and structural characterization of the interaction between the FMN binding domain of cytochrome P450 reductase and cytochrome c.Enhancement of antitumor drug cytotoxicity via laser photoactivation.Differential toxicity of mitomycin C and porfiromycin to aerobic and hypoxic Chinese hamster ovary cells overexpressing human NADPH:cytochrome c (P-450) reductaseProbing the transmembrane structure and dynamics of microsomal NADPH-cytochrome P450 oxidoreductase by solid-state NMR.Evaluation of the mutagenicity and antimutagenicity of Ziziphus joazeiro Mart. bark in the micronucleus assay.Engineering of a functional human NADH-dependent cytochrome P450 systemMyocet (liposome-encapsulated doxorubicin citrate): a new approach in breast cancer therapy.A chemical perspective on the anthracycline antitumor antibioticsTurnover of bacterial glutamine synthetase: oxidative inactivation precedes proteolysisRole of hydrogen peroxide and hydroxyl radical formation in the killing of Ehrlich tumor cells by anticancer quinones.Analytical tools for the analysis of β-carotene and its degradation products.Cytolytic T lymphocytes and antibodies to myocytes in adriamycin-treated BALB/c mice. Evidence for immunity to drug-induced antigens.Synthesis and evaluation of antitumor activity of novel N-acyllavendamycin analogues and quinoline-5,8-dionesPro-oxidant and antioxidant effects of N-acetylcysteine regulate doxorubicin-induced NF-kappa B activity in leukemic cellsBorrelia burgdorferi, a pathogen that lacks iron, encodes manganese-dependent superoxide dismutase essential for resistance to streptonigrin.Pharmacokinetics of the perioperative use of cancer chemotherapy in peritoneal surface malignancy patientsFormation of reactive oxygen species during one-electron reduction of noradrenochrome catalyzed by NADPH-cytochrome P-450 reductase.An evaluation of hepatic extraction and clearance of doxorubicin.Coenzyme q10 for prevention of anthracycline-induced cardiotoxicity.Synthesis of adriamycin-coupled polyglutaraldehyde microspheres and evaluation of their cytostatic activity.Increase of NAD(P)H:quinone reductase by dietary antioxidants: possible role in protection against carcinogenesis and toxicity.Depletion of topoisomerase II in isolated nuclei during a glucose-regulated stress responseDistinct roles of cytochrome P450 reductase in mitomycin C redox cycling and cytotoxicity.A discovery study of daunorubicin induced cardiotoxicity in a sample of acute myeloid leukemia patients prioritizes P450 oxidoreductase polymorphisms as a potential risk factor.Semiquinone radicals from oxygenated polychlorinated biphenyls: electron paramagnetic resonance studies.Relationship between the pharmacological activity of antitumor drugs Ametantrone and mitoxantrone (Novatrone) and their ability to condense nucleic acids.Encapsulation of adriamycin in human erythrocytes.Pharmacogenetics of genes across the doxorubicin pathway.Current status of epirubicin (Farmorubicin) in the treatment of solid tumours.Imaging of early modification in cardiomyopathy: the doxorubicin-induced model.The pentose phosphate pathway and cancer.Use of oligonucleotides to define the site of interstrand cross-links induced by Adriamycin.Fanconi anemia (FA) and crosslinker sensitivity: Re-appraising the origins of FA definition.Mitoxantrone, More than Just Another Topoisomerase II Poison.Combined effects of p-coumaric acid and naringenin against doxorubicin-induced cardiotoxicity in rats.Release of iron from ferritin and its role in oxygen radical toxicities.
P2860
Q24606920-F6C81CC7-E118-4997-964E-7C661966D598Q26780547-CE6754B0-03EB-4197-82F7-8D3A2061DC39Q28379069-8B219D1A-6B7A-4C73-99AB-9DDC1E7BEBFFQ28477095-F0DBA18D-7038-4010-9514-0C5665B86CCFQ30369811-DB8DDBBD-7B7B-47A3-9BFD-91E53A62E56EQ33376255-4541C5EF-365D-46A0-AF7C-30ABB7F79CA9Q33630320-1EE65569-2954-4632-85B7-CC2E7290F678Q33736588-EFC09FFF-CAED-42F3-95A6-BBF746E4AD75Q33890365-FA538BEB-273F-4B35-93EC-0542FE932B73Q34583746-1F190387-600F-4A30-A219-EF83D5C95DBBQ35020538-DC4CB970-2663-4180-82C8-8DF960F54191Q35035606-5C451AFB-EC7D-4D6F-AF90-22C34891AF28Q35342066-D5E80D65-031D-4A40-937A-685DF7FB02F8Q35612344-CFE51476-34BF-4769-9535-FB78B2DC849BQ35805387-080B492D-B894-4A45-97F4-A0515ECCE6CDQ35830962-5764A442-89F2-4226-AFA9-BBEFE1ED93E5Q35857145-4D2DB371-B902-45D7-B8E8-9C937525058AQ35915757-7429FA9E-71D9-4BA3-8C65-52F314259773Q36003761-E2425B5A-D08C-4821-A875-C5FDFAFF5CC7Q36063487-1407BF91-25B3-432A-B247-25419BBA4F1BQ36077131-B7E84163-A1C7-48F3-8D0B-F3C580423CD0Q36081838-AA5FCB51-CE5A-4CF4-A05D-78668206E3BBQ36136382-DCEB15D4-771B-40A6-A7C3-AE45F18D8720Q36287939-F6461203-547E-43C7-9A10-37DFC2467F88Q36405515-A2432CCC-51C8-4A19-B7A9-71989ACCF0FDQ36758651-1083FD87-B787-46AB-A441-37E365B2ED42Q37192362-112044F0-A56D-49C3-AF39-43FE943EA47FQ37293202-D7C0C323-D239-4970-96A9-38A202F72E8FQ37338890-2F30B336-4033-401B-9969-2F60FCF9118BQ37396644-7232B355-7C6E-471A-ADFF-86ED922E3CE4Q37399860-88EE79BB-D701-43D8-8FBF-E3362EA1D551Q37932556-8B621027-38A5-4C92-B199-2AFAF7AF1234Q37938298-FBF38197-DECA-465C-A34E-AFA58689F967Q38112616-2C302DA6-4738-4B91-8591-4995235919E7Q38231069-FF601183-28BE-48A5-9982-53B35981A5ABQ38293455-E7A3B434-C6FB-4E38-BAB5-8AB04A87EB94Q38366827-EE068C58-AAF8-4194-9617-1F24D7BEC26BQ38569206-7947677A-9C86-4287-9A5C-E82EA65AEC50Q38709285-F3100868-967F-459E-AE5F-185E416E2F34Q39318466-E9074C64-A40F-4FC9-8BF9-AE9C4DF60642
P2860
NADPH cytochrome P-450 reductase activation of quinone anticancer agents to free radicals.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 1979
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
NADPH cytochrome P-450 reducta ...... ancer agents to free radicals.
@en
NADPH cytochrome P-450 reducta ...... ancer agents to free radicals.
@nl
type
label
NADPH cytochrome P-450 reducta ...... ancer agents to free radicals.
@en
NADPH cytochrome P-450 reducta ...... ancer agents to free radicals.
@nl
prefLabel
NADPH cytochrome P-450 reducta ...... ancer agents to free radicals.
@en
NADPH cytochrome P-450 reducta ...... ancer agents to free radicals.
@nl
P2093
P2860
P356
P1476
NADPH cytochrome P-450 reducta ...... ancer agents to free radicals.
@en
P2093
P2860
P304
P356
10.1073/PNAS.76.2.954
P407
P577
1979-02-01T00:00:00Z